Get 15% OFF with code GROWNOW15
My Account Order Lookup Cannabis Guides Beginner Seeds Intermediate Seeds Master Seeds

Ogre – Strain Information

  • Home
  • Ogre – Strain Information

Table of Contents

Ogre is a potent indica-dominant hybrid cannabis strain, widely recognized for its fast-flowering genetics, dense trichome-rich buds, and deeply sedative effects. Though sometimes confused with other phenotypes or similar-named cultivars (e.g., Ogre OG, Ogre Kush), the original Ogre is often traced back to Sensi Star genetics or a hybrid cross involving Master Kush, Bubba Kush, and Afghani lineage strains. Ogre is well-regarded among medical and recreational consumers for its high THC levels, soothing body high, and efficacy in pain and stress relief.

ogre appearance
Genetic Lineage and Origin
Primary Genetic Line
  • Sensi Star Cut (Paradise Seeds): Some reports cite Ogre as a phenotype of Sensi Star, known for its heavy indica traits.
  • Alternative Crosses:
    • Master Kush × Bubba Kush × Afghani
    • Ogre OG (OG Kush phenotype) crossed with SFV OG or Sour Diesel hybrids (in variant strains)

Because multiple cultivars have used the “Ogre” moniker, it’s essential to distinguish between:

  • Ogre (indica-dominant)
  • Ogre OG (more hybrid or sativa-leaning in certain expressions)
Morphology and Cultivation Characteristics
I. Genetic Traits Influencing Cultivation

Genotype Expression:

  • Ogre exhibits indica-dominant morphology (broad leaves, squat structure) but often shows hybrid vigor, especially in environments with ample light and optimized nutrients.
  • It’s photoperiod-dependent, meaning light cycle manipulation is crucial for flowering induction.

Phenotypic Traits:

  • Fast flowering (42–56 days)
  • High trichome production
  • Resistance to mold and mildew (linked to Afghani ancestry)
  • Responds well to stress training due to stem thickness and internodal spacing
Germination and Vegetative Phase
1. Germination
  • Ideal temp: 22–25°C (72–77°F)
  • pH: 6.0–6.5 for rockwool or peat pellets
  • Germination rate is high with feminized seeds, but regular seeds can be used for phenohunting.
2. Vegetative Growth Parameters
  • Light Cycle: 18/6 (hours light/dark)
  • Light Intensity: 400–600 PPFD (Photosynthetic Photon Flux Density)
  • Temperature: 24–28°C (75–82°F)
  • Humidity: 55–70% RH
  • Soil pH: 6.2–6.5 (in soil), 5.8–6.2 (in hydro)

Nutrient Focus:

  • High nitrogen (N) for foliage development
  • Moderate phosphorus (P) and potassium (K)
  • Calcium and magnesium (especially in coco or hydro systems)

Training Techniques:

  • Low-Stress Training (LST): Enhances lateral branching and light penetration
  • Topping: Effective for bushier growth
  • Screen of Green (ScrOG): Ideal due to Ogre’s lateral growth tendency
Flowering Phase
1. Photoperiod Manipulation
  • Light Cycle: 12/12
  • Transition to flowering typically begins within 7–10 days of light cycle change.
2. Environmental Control
  • Temperature: 20–26°C (day), 18–22°C (night)
  • Humidity: 40–50% RH to avoid bud rot
  • CO₂ Enrichment: Up to 1200–1500 ppm can boost flower mass
3. Nutrient Schedule
  • Week 1–3 (Early Flowering):
    • Moderate nitrogen
    • High phosphorus to initiate bud sites
  • Week 4–6 (Mid-Flowering):
    • High potassium for bud density
    • Sulfur and magnesium to aid in the production of terpenes
  • Week 6–8 (Ripening):
    • Reduce nitrogen
    • Focus on potassium, micronutrients, and flushing

Note: Ogre responds well to organic compost teas, molasses feeding, and microbial inoculants (like mycorrhizae or Trichoderma) to improve terpene profiles.

Terpene and Cannabinoid Optimization
ogre ee
1. Light Quality
  • Full-spectrum LED or CMH (ceramic metal halide) lighting encourages trichome and terpene synthesis.
  • UVB exposure in final weeks increases resin and THC production (scientific support: THC acts as a UV protectant).
2. Stress Conditioning
  • Mild water stress during late flowering (by gradually decreasing watering frequency) stimulates cannabinoid production.
  • Temperature variation (cooler nights) helps preserve terpenes like limonene and linalool.
3. Harvest Timing
  • Trichome color monitoring (via loupe or microscope):
    • Cloudy → peak THC
    • Amber → more CBN, sedative effect (ideal for Ogre)

Scientific Strategy: Harvest at 10–20% amber trichomes to maximize Ogre’s heavy indica sedation effect.

Medium Selection: Pros and Cons for Ogre
MediumProsCons
SoilRich terpene profiles; easier bufferingSlower growth; less precise control
Coco CoirFast growth; good aerationRequires more frequent feeding; pH sensitive
Hydroponics (DWC, NFT)Explosive growth and yieldRequires tight control over EC/pH; risk of root issues

Ogre does particularly well in coco blends with 30–40% perlite due to strong root oxygenation and fast nutrient uptake.

Integrated Pest and Mold Management
Natural Resistance
  • Ogre is relatively mold-resistant due to tight internodal structure and dense foliage, but:
    • Needs defoliation during mid-flower to ensure airflow
    • Buds must be spaced for drying to avoid moisture entrapment
ogre
IPM Strategy
  • Neem oil (veg stage only) for aphids, mites
  • Bacillus subtilis or lactobacillus foliar sprays for PM (powdery mildew)
  • Beneficial insects: Hypoaspis miles (soil pests), Phytoseiulus persimilis (spider mites)
Post-Harvest: Curing for Maximum Effect
1. Drying Conditions
  • Temperature: 18–20°C (64–68°F)
  • Humidity: 50–60% RH
  • Duration: 7–10 days, slow-dried in dark space
2. Curing Method
  • Glass jars, burped daily for first 2 weeks
  • After 30–45 days, terpene concentration stabilizes
  • Proper curing significantly increases flavor, smoothness, and psychoactive clarity
Yield Estimates (Optimized Conditions)
Grow MethodYield (per plant)
Indoor (soil)400–500g/m²
Indoor (hydro)500–600g/m²
Outdoor (full sun, organic)600–900g per plant
Cultivation Challenges & Solutions
ChallengeSolution
OverwateringAllow near-dryback before next watering
Dense canopy → mold riskLollipop technique + defoliation
Nutrient burnStart with 50% strength and monitor EC
Temperature swingsUse thermostat-controlled intake/exhaust fans
Cannabinoid Profile
CompoundTypical Range
THC18–24%
CBD<0.5%
CBG0.3–1%
THCVTrace
CBCTrace–0.2%

The high THC content combined with minor cannabinoids like CBG contributes to Ogre’s strong psychoactive and therapeutic profile.

Terpene Profile and Aromatics
Dominant Terpenes
  • Myrcene: Sedative, analgesic, muscle relaxant
  • Caryophyllene: Anti-inflammatory, interacts with CB2 receptors
  • Limonene: Mood enhancement, anti-anxiety
  • Linalool: Calming, anti-epileptic
  • Humulene (lesser presence): Appetite suppressant
Aroma and Flavor Profile
  • Aromatics: Earthy, pungent, spicy with herbal notes
  • Flavor: Diesel undertones, sweet citrusy finish with kushy earth

The terpene mix gives Ogre its heavy aroma, reminiscent of dank kush crossed with subtle floral-citrus notes.

Recreational Effects
1. Onset and Duration
  • Time to onset: ~5–10 minutes (inhalation)
  • Peak effects: 30–60 minutes
  • Duration: 2–3 hours (inhalation), longer for edibles
2. Psychoactive Effects
  • Relaxation: Immediate and full-body
  • Euphoria: Mild to moderate cerebral uplift, not overly intoxicating
  • Sedation: Strong, especially at higher doses
  • Couch-lock: Common, especially for novice users
3. Ideal Recreational Contexts
  • Evening use
  • Watching movies or relaxing
  • Social smoking in low-energy settings
  • Deep sleep preparation
4. Potential Side Effects
  • Dry eyes and mouth (common)
  • Dizziness in low-tolerance users
  • Heavy sedation—may impair productivity
Medical Applications

Ogre is an indica-dominant strain with high THC levels (18–24%) and a terpene profile led by myrcene, caryophyllene, limonene, and linalool. Its medical efficacy is driven by:

  • THC: Analgesic, anti-nausea, appetite stimulant
  • Myrcene: Sedative, muscle relaxant, synergist with THC
  • Caryophyllene: Anti-inflammatory, acts on CB2 receptors
  • Linalool: Anxiolytic, anticonvulsant
  • Limonene: Mood stabilizer, antidepressant

This combination offers multi-modal relief across neurological, musculoskeletal, gastrointestinal, and psychiatric conditions.

Pain Management
Clinical Indications
  • Neuropathic pain (e.g., diabetic neuropathy, MS)
  • Inflammatory pain (arthritis, lupus)
  • Chronic back/neck pain
  • Post-surgical pain
Mechanisms
  • THC activates CB1 receptors in the spinal cord and brain, dampening pain signal transmission.
  • Caryophyllene activates CB2 receptors in immune tissues, reducing inflammatory cytokine production.
  • Myrcene modulates TRPV1 (pain and temperature channel), providing local analgesia.
Scientific Evidence
  • Animal models show CB1 receptor agonists reduce nociceptive thresholds.
  • Human trials with high-THC strains demonstrate significant improvement in pain scores in chronic pain and cancer patients.
  • Myrcene enhances blood-brain barrier permeability, increasing THC’s central effects.
Insomnia and Sleep Disorders
Clinical Indications
  • Sleep onset insomnia
  • Maintenance insomnia
  • Sleep disturbance secondary to pain or PTSD
Mechanisms
  • Myrcene promotes sedation via GABAergic transmission enhancement.
  • THC reduces REM sleep (helpful in PTSD nightmares), increases slow-wave sleep.
  • Linalool increases adenosine signaling, inducing sleepiness.
Scientific Insight
  • A 2013 study in Frontiers in Psychiatry showed THC decreased sleep latency and increased total sleep time.
  • Myrcene alone (at high concentrations) has a similar sedative effect as benzodiazepines in rodent studies.
Anxiety and PTSD
Clinical Indications
  • Generalized anxiety disorder (GAD)
  • Social anxiety
  • PTSD-related hyperarousal
  • Acute stress response
Mechanisms
  • Linalool reduces activity in the amygdala and hypothalamus (key fear/anxiety centers).
  • Limonene upregulates dopamine and serotonin signaling in the hippocampus.
  • THC in low doses can reduce cortisol and induce calm, though high doses may trigger anxiety in some individuals.
Dosing Consideration
  • Low-THC doses (<5mg inhaled) show anxiolytic effect; higher doses may reverse it.
  • Ideal for evening or nighttime anxiety, especially when insomnia is also present.
Depression and Mood Disorders
Clinical Indications
  • Mild-to-moderate depression
  • Anhedonia and low motivation
  • Bipolar depression (cautious use)
Mechanisms
  • Limonene increases neurotrophic signaling (BDNF, NGF) in animal models, supporting mood and neuroplasticity.
  • THC temporarily boosts dopamine release in the striatum, elevating mood and motivation.
  • CB1 activation in limbic regions mediates reward and pleasure pathways.
Considerations
  • Chronic or high-dose THC use can cause dysphoria in some patients—must be personalized.
  • Ideal for situational depression or depressive states related to pain/fatigue.
Muscle Spasms and Spasticity
Clinical Indications
  • Multiple sclerosis (MS)
  • Spinal cord injury
  • Cerebral palsy
  • Parkinsonian tremors
Mechanisms
  • THC reduces motor neuron excitability via CB1 interaction in the spinal cord.
  • Myrcene and linalool possess antispasmodic and muscle relaxant properties.
  • CB2 modulation via caryophyllene lowers inflammatory processes around motor neurons.
Scientific Support
  • Nabiximols (a 1:1 THC:CBD oral spray) is approved in parts of Europe for MS-related spasticity.
  • Ogre may mimic these effects due to its potent THC and terpene synergy, even in the absence of high CBD.
Appetite Stimulation
Clinical Indications
  • Cancer cachexia
  • HIV/AIDS-related wasting
  • Anorexia
  • Chronic illness with weight loss
Mechanisms
  • THC binds to CB1 receptors in the hypothalamus, stimulating hunger signals.
  • Dopaminergic and endorphin-related reward circuits are activated, enhancing food enjoyment.
Evidence
  • Dronabinol (synthetic THC) is FDA-approved for AIDS wasting and chemo-induced anorexia.
  • Whole-plant cannabis (like Ogre) often performs better than isolates due to entourage effect.
Gastrointestinal Disorders
Clinical Indications
  • Irritable bowel syndrome (IBS)
  • Crohn’s disease
  • Ulcerative colitis
  • Functional abdominal pain
Mechanisms
  • CB1/CB2 receptors in the enteric nervous system regulate gut motility, inflammation, and nausea.
  • Caryophyllene has documented anti-inflammatory action in the GI tract.
  • Linalool and limonene modulate visceral pain and smooth muscle spasm.
Evidence
  • Clinical trials show cannabinoids reduce inflammatory markers and symptom severity in Crohn’s and IBS.
  • Ogre’s high THC and caryophyllene content make it suitable for symptom control, especially in flare-ups.
Nausea and Chemotherapy-Induced Vomiting
Clinical Indications
  • Chemotherapy
  • Radiation therapy
  • Chronic nausea (gastroparesis, migraine, liver disease)
Mechanisms
  • THC inhibits emetic reflex via CB1 activation in the dorsal vagal complex of the brainstem.
  • Rapid onset via inhalation → quick symptom relief
  • Limonene and myrcene support anti-nausea effect
Comparison
  • Similar or superior to pharmaceutical agents (e.g., ondansetron) in resistant cases
  • Works best as inhaled formulation for breakthrough nausea
Inflammation and Autoimmune Disorders
Clinical Indications
  • Rheumatoid arthritis
  • Lupus
  • IBD (Crohn’s/UC)
  • Psoriasis
Mechanisms
  • Caryophyllene is one of the few terpenes shown to selectively bind to CB2, a key anti-inflammatory receptor.
  • THC also inhibits COX-2 and TNF-α, both inflammatory mediators.
  • Myrcene and limonene reduce oxidative stress and inflammatory cytokines.
Scientific Backing
  • Animal models show significant edema and cytokine suppression via CB2 agonism with caryophyllene.
  • Ogre’s anti-inflammatory profile is ideal for symptom management in flare-up stages.
Neurological Conditions and Seizures

Though Ogre lacks significant CBD, some components still offer adjunctive neurological benefit.

Potential Benefits
  • Mild seizure resistance due to linalool’s modulation of glutamate and GABA.
  • THC may stabilize neuronal overexcitation in certain forms of epilepsy (not first-line).
  • Neuroprotective antioxidant activity from limonene and caryophyllene.

Note: High-THC strains should be used cautiously in epilepsy and only under clinical supervision.

Summary Table of Medical Uses
ConditionMechanismsKey Compounds
Chronic painCB1/CB2 activation, TRPV1 modulationTHC, caryophyllene, myrcene
InsomniaGABAergic modulation, adenosine enhancementMyrcene, THC, linalool
AnxietyAmygdala inhibition, serotonin modulationLinalool, limonene
Appetite lossCB1 activation in hypothalamusTHC
GI disordersEnteric CB1/CB2 modulation, spasm controlCaryophyllene, myrcene
Muscle spasmsMotor neuron stabilizationTHC, linalool, myrcene
InflammationCB2 activation, cytokine inhibitionCaryophyllene, THC
DepressionDopamine & serotonin stimulationLimonene, THC
Scientific Insights and Mechanisms of Action
1. Endocannabinoid System Interactions
  • THC binds to CB1 receptors (central nervous system) → psychoactivity, analgesia, sedation
  • Caryophyllene selectively targets CB2 (immune system) → anti-inflammatory effects without psychotropic effects
  • Myrcene and linalool act on TRPV1 channels and GABAergic receptors → muscle relaxation and sleep enhancement
2. Entourage Effect

Ogre’s multi-terpene synergy exemplifies the entourage effect, where terpenes and cannabinoids work in concert to amplify therapeutic outcomes. Myrcene and limonene boost THC’s bioavailability across the blood-brain barrier, while linalool and caryophyllene offset excitotoxicity and inflammation.

3. Pharmacokinetics
  • Onset: Rapid via inhalation (5–10 min)
  • Metabolism: First-pass hepatic metabolism (for edibles) increases 11-hydroxy-THC, intensifying sedation
  • Half-life: THC’s active effects diminish after 2–3 hours; metabolites may linger in chronic users
4. Safety Profile
  • No known lethal dose
  • Risk of dependency is low to moderate, especially in users prone to sedative substance use
  • Avoid combining with other CNS depressants
Comparison with Similar Strains
StrainTypeTHC RangeSimilaritiesDifferences
Sensi StarIndica-dominant16–20%Sedation, fast floweringLess euphoric uplift than Ogre
Master KushIndica-dominant18–22%Body relaxation, stress reliefEarthier, less citrus notes
Bubba KushPure Indica15–22%Deep sedation, insomnia reliefSlower to flower
SFV OGHybrid (OG Kush)20–25%Pungent, earthy-diesel aromaMore cerebral effects, less sedative
User Demographics and Popularity
Preferred by:
  • Medical patients seeking sleep, pain, and anxiety relief
  • Recreational users preferring relaxing, evening strains
  • Cultivators due to short flowering time and yield
  • Popular in:
    • California
    • Oregon
    • Colorado
    • Select Canadian provinces
  • Often available in pre-rolls, concentrates, and edibles due to rich resin content
Concentrate and Edible Use

Ogre’s dense trichomes make it ideal for:

  • Live resin
  • Shatter
  • Rick Simpson Oil (RSO)
  • Tinctures and edibles

The terpene retention in live resin forms enhances its sedative and euphoric effects when vaporized.

Breeding and Hybridization
Breeding Use
  • Commonly used in breeding short-flowering indica strains with diesel or kush aromatics.
  • Hybrids involving Ogre include:
    • Ogre Berry (Ogre × Island Strawberry Afghani)
    • Madman OG (Ogre OG × LA Confidential)

These crosses often retain Ogre’s heavy sedative effect with novel flavor/aroma profiles.

Conclusion

The Ogre cannabis strain stands out for its potent sedative properties, fast growth cycle, and robust cannabinoid-terpene synergy. With medical applications ranging from chronic pain and insomnia to stress and appetite disorders, Ogre is a cornerstone indica strain that offers high therapeutic value without overwhelming cognitive effects.

Its unique biochemical makeup—highlighted by high THC, myrcene, and caryophyllene—creates a powerful body high with a touch of euphoria, making it suitable for both medical patients and recreational users seeking relaxation and relief.

For a complete directory of cultivars, visit our Cannabis Strain Reviews.